Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $31.1700 (5.77%) ($29.6100 - $31.4400) on Fri. Oct. 9, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.8% (three month average) | RSI | 40 | Latest Price | $31.1700(5.77%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -0.2% a day on average for past five trading days. | Weekly Trend | IOVA declines -4.9% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(47%) XBI(44%) ARKG(43%) IWO(41%) ARKK(39%) | Factors Impacting IOVA price | IOVA will decline at least -1.9% in a week (0% probabilities). VIXM(-23%) UUP(-16%) VXX(-12%) TBT(-6%) UNG(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.9% (StdDev 3.8%) | Hourly BBV | 1.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $17.55(-43.7%) | Inflection Point | Yes | Resistance Level | $32.6 | 5 Day Moving Average | $29.77(4.7%) | 10 Day Moving Average | $31.05(0.39%) | 20 Day Moving Average | $32.6(-4.39%) | To recent high | -14% | To recent low | 12.3% | Market Cap | $4.564b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |